David Hague Early Career Investigator of the Year Award

Sponsor: Alzheimer’s Research UK

Award: £25,000 research expenses and £1,500 personal prize

Due Date: 27 September 2019

Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) (RFA-AG-20-010)

Sponsor: National Institute on Aging

Award: NIA intends to commit $2 million in FY 2020 to fund approximately seven to 10 awards for this RFA and its companion. Future year amounts are contingent upon annual appropriations.

Due Date: October 22, 2019, by 5 p.m. local time of applicant organization.

Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) (RFA-AG-20-011)

Sponsor: National Institute on Aging

Award: NIA intends to commit $2 million in FY 2020 to fund approximately seven to 10 awards for this RFA and its companion. Future year amounts are contingent upon annual appropriations.

Due Date: October 22, 2019, by 5 p.m. local time of applicant organization.

Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) (PAS-19-317)

Sponsor: National Institute on Aging

Award: NIA intends to fund an estimate of 10 awards, corresponding to a total of $4 million for fiscal year 2020. Future year amounts will depend on annual appropriations.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity are due on these dates. The first standard application due date for this FOA is January 5, 2020.

Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) (PAS-19-316)

Sponsor: National Institute on Aging

Award: NIA intends to fund an estimated 40 awards, corresponding to a total of $20 million, for fiscal year 2020. Future year amounts will depend on annual appropriations.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity are due on these dates. The first standard application due date for this FOA is January 5, 2020.

NIA Program Project Applications (P01 Clinical Trial Optional) (PAR-19-314)

Sponsor: National Institute on Aging

Due Date: Standard dates apply. The first standard due date for this FOA is September 25, 2019. All applicants are due by 5 p.m. local time of applicant organization.

Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) (PAR-19-315)

Sponsor: National Institute of Neurological Disorders and Stroke; National Institute on Aging

Due Date: September 4, 2019; February 14, 2020; July 20, 2020; February 17, 2021; July 19, 2021; and February 14, 2022, by 5 p.m. local time of applicant organization.

Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD) (R01 Clinical Trial Not Allowed) (RFA-NS-20-004)

Sponsor: National Institute of Neurological Disorders and Stroke; National Institute on Aging

Award: October 9, 2019, by 5 p.m. local time of applicant organization.

Due Date: NIH intends to fund approximately six to eight awards, corresponding to $4.5 million total cost, for fiscal year 2020. Future year amounts will depend on annual appropriations.

Lipid Signaling in Healthspan and Longevity Regulation (R01 Clinical Trial Not Allowed) (RFA-AG-20-039)

Sponsor: National Institute on Aging

Award: NIA intends to commit $1 million in FY 2020 to fund four or five awards.

Due Date: February 3, 2020, by 5 p.m. local time of applicant organization.

Implementation Research on Hypertension Control to Prevent Dementia and Cognitive Decline (R61/R33 Clinical Trial Optional) (RFA-AG-20-028)

Sponsor: National Institute on Aging

Award: NIA intends to commit $2 million in direct costs in FY 2020 to fund two to four awards.

Due Date: October 22, 2019, by 5 p.m. local time of applicant organization.

Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-AG-20-021)

Sponsor: National Institute on Aging

Award: NIA intends to commit $400,000 in total costs in 2020 to support one award.

Due Date: October 22, 2019, by 5 p.m. local time of applicant organization.

Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed) (RFA-AG-20-020)

Sponsor: National Institute on Aging

Award: NIA intends to commit $7 million in FY 2020 to fund an estimated six to eight awards.

Due Date: October 21, 2019, by 5 p.m. local time of applicant organization.

Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) (RFA-AG-20-018)

Sponsor: National Institute on Aging

Award: NIA intends to commit a total of $2.4 million in FY 2020 to fund approximately 15 awards.

Due Date: October 2, 2019, by 5 p.m. local time of applicant organization.

Transition to Aging Research for Predoctoral Students (F99/K00) (RFA-AG-20-009)

Sponsor: National Institute on Aging

Award: NIA intends to commit $450,000 in FY 2020 to fund seven to 10 awards.

Due Date: October 22, 2019, by 5 p.m. local time of applicant organization.

FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) (PAR-19-306)

Sponsor: Food and Drug Administration

Due Date: October 11, 2019, by 11:59 p.m. Eastern Time. April 13, 2020, and October 13, 2020, by 11:59 p.m. Eastern Time. April 12, 2021, and October 12, 2021, by 11:59 p.m. Eastern Time. April 12, 2022, and October 11, 2022, by 11:59 p.m. Eastern Time.